Roots Analysis

• RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035

  Apr 28, 2022  |  Published by: Roots Analysis  |  USD 4,799

  RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035 INTRODUCTION RNAi therapeutics have garnered significant attention post the 2006 Nobel Prize that was awarded to Andrew Fire and Craig Mello for the discovery of RNA interference (RNAi). Su ... Read More

• Metabolomics Services Market, 2022-2035

  Apr 13, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Since the initiation of the Human Metabolome Project in 2005, the metabolomics technique has gathered significant attention from the industry stakeholders. It is worth mentioning that about 40,000 small molecules constitute the human metabolome. Further, 30% of the known genetic disorders are associ ... Read More

• Women’s Digital Health Market, 2022-2035

  Apr 05, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Women’s Digital Health Market, 2022-2035 1.1. SCOPE OF THE REPORT Over the past few years, there have been several advancements in the field of digital health; this has led to an increase in the adoption of digital healthcare solutions. Specifically, the outbreak of COVID-19 pandemic prompted people ... Read More

• Investor Series: Opportunities in the Cell and Gene Therapy Market

  Apr 04, 2022  |  Published by: Roots Analysis  |  USD 1,899

  Investor Series: Opportunities in the Cell and Gene Therapy Market Contemporary medical science has traced thousands of clinical conditions to a genetic cause. Cancer, a life-threatening disease, also has genetic origins, and is considered among the leading causes of death across the globe. In fact, ... Read More

• Aptamers: Therapeutics, Technologies, and Services Market, 2022-2035

  Mar 31, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Aptamers: Therapeutics, Technologies, and Services Market, 2022-2035 Post the approval of the first aptamer-based therapy, Macugen®, by the US Food and Drug Administration (USFDA) in December 2004, there has been a significant increase in the R&D initiatives focused on evaluating the potential o ... Read More

• Novel Cardiovascular Drug Delivery Devices Market, 2022-2035

  Mar 31, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Novel Cardiovascular Drug Delivery Devices Market, 2022-2035 Cardiovascular diseases (CVD) are reported to be one of the leading causes of deaths across the globe, surpassing conditions, such as cancer and respiratory disorders. According to the WHO, around one third of the annual global deaths (an ... Read More

• Plant-based Meats: Intellectual Property Landscape

  Mar 30, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Plant-based Meats: Intellectual Property Landscape In 2020, close to 340 million tons of meat was estimated to be produced worldwide. Compared to the early 1960s (~70 million tons), this represents almost a 500% increase. Considering that the global population grew by 150% in the same time period, i ... Read More

• Gene Therapies & Associated Vectors: Intellectual Property Landscape

  Mar 30, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Gene Therapies & Associated Vectors: Intellectual Property Landscape Although speculations related to using tailored DNA / RNA sequences to cure genetic disorders were made as early as the 1960s, the first reported use of a gene therapy was in 1990, to treat adenosine deaminase (ADA) deficiency rela ... Read More

• CAR-T Cell Therapies: Intellectual Property Landscape

  Mar 30, 2022  |  Published by: Roots Analysis  |  USD 1,299

  CAR-T Cell Therapies: Intellectual Property Landscape Cancer, one of the leading causes of death worldwide, claimed close to 10 million lives annually Although there are several treatment options available to control disease progression and keep malignant cells from spreading throughout the body, l ... Read More

• Vaccine Adjuvant Market (2nd Edition), 2022-2035

  Mar 19, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Vaccine Adjuvant Market (2nd Edition), 2022-2035 As per recent estimates (reported in May 2022), more than 11.6 billion doses of COVID-19 vaccines have been administered across 184 countries; this value roughly translates to 20.9 million doses per day. Vaccines have enabled the prevention of more t ... Read More

• Viral Vaccine Cell Culture Media Market, 2022-2035

  Mar 11, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Viral Vaccine Cell Culture Media Market, 2022-2035 Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fac ... Read More

• Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035

  Mar 01, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035 Since the approval of Orthoclone OKT3, a murine monoclonal antibody against T cell expressed CD3 (for the treatment of acute transplant rejection) in 1986, antibody based pharmacological interventions have evolved into a promi ... Read More

• Flow Cytometry Services Market, 2022-2035

  Feb 15, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Flow Cytometry Services Market, 2022-2035 First introduced in 1950s, the flow cytometry technique has gained significant attention in the past few decades. This can be attributed to the fact that flow cytometry has been demonstrated to be capable of overcoming various challenges associated with conv ... Read More

• Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035

  Feb 09, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More

• Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

  Feb 02, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for No ... Read More

• Artificial Intelligence in Healthcare: Intellectual Property Landscape

  Jan 24, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Artificial Intelligence in Healthcare: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) The globa ... Read More

• Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific)

  Jan 07, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific) 1. It is a well-known fact that c ... Read More

• Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company Valuation Analysis, [F] Financial Analysis of Key Public Ventures, [G] Market Forecast and Opportunity Analysis, [H] Insights from Publicly Disclosed Investor Exits and [I] Key Acquisition Targets)

  Jan 04, 2022  |  Published by: Roots Analysis  |  USD 5,999

  Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company ... Read More

< prev 5 6 7 8 9 10 next >